戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  at 5-10-fold lower concentrations than when unencapsulated.
2 cluded 144 (84.2%; 95% CI, 77.9%-89.3%) with unencapsulated, 11 (6.4%; 95% CI, 3.3%-11.2%) with serot
3 imulated sunlight in ambient atmosphere, our unencapsulated and encapsulated cells retain 80 and 95%
4 trolling oxidative changes in both oils than unencapsulated and synthetic one, however, extract encap
5 e vascular cell adhesion molecules, with the unencapsulated and truncated LOS strains being most pote
6 umoniae early lung infection with wild-type, unencapsulated, and para-amino benzoic acid auxotroph mu
7      Both NP formulations of AZ3451, but not unencapsulated AZ3451, caused long-lasting analgesia and
8              NP-encapsulated AZ3451, but not unencapsulated AZ3451, rapidly and completely reversed P
9 primed or primed in vivo host lymphocytes to unencapsulated BAC cells in vitro.
10 r alveolar macrophage-dependent clearance of unencapsulated bacteria.
11 immune response relative to vaccination with unencapsulated BCG, including higher polysaccharide-spec
12  pharmacokinetics and efficacy compared with unencapsulated BPTES.
13 particular serotype by SAST were shown to be unencapsulated by PCR, and two isolates that were report
14 ate other applications, including removal of unencapsulated calcein from vesicles, remote loading and
15 L/mL) and AFB(1) production (0.4 uL/mL) over unencapsulated carvone along with promising antioxidant
16 n contrast, the control animal that received unencapsulated cells exhibited a complete loss of cell s
17 nd invasion of epithelial cells and that the unencapsulated cells within the population preferentiall
18 sults in two populations of encapsulated and unencapsulated cells.
19  were stimulated with encapsulated (COH1) or unencapsulated (COH1-13) whole type III GBS or with puri
20  were stimulated with encapsulated (COH1) or unencapsulated (COH1-13) whole type III GBS or with puri
21 sveratrol from dialysis bags compared to the unencapsulated compound.
22 ive encapsulated mutants compared with their unencapsulated counterparts (p < 0.01) when purified C1
23 o nanocapsules with one polyphenol and their unencapsulated counterparts.
24  readily achieved at the device level, where unencapsulated CsPbI(3) perovskite photodetectors displa
25 ented under an ambient-air condition for the unencapsulated CsSnI(3)-MBAA PSC.
26                                              Unencapsulated Deltapbp1a D39 mutants have smaller diame
27 ate, and laboratory strain R6, an avirulent, unencapsulated derivative of strain D39.
28                                          The unencapsulated device maintains 90% of its initial effic
29                                          The unencapsulated devices based on HiBT HTM retained over 8
30              Furthermore, the performance of unencapsulated devices remains unchanged for over 150 da
31                                          The unencapsulated devices retained about 82% of the initial
32                                          The unencapsulated devices show record operational stability
33 g in 500 micro L, n = 6) or intravenous free unencapsulated doxorubicin (n = 7) was administered imme
34 d to calculate nanomedicine encapsulated and unencapsulated drug fractions.
35 harboured within bladder cells compared with unencapsulated drug.
36 atio and photobleaching resistance versus an unencapsulated dye.
37 ethylsilyl)pyrazine occurs first at only the unencapsulated exo oxo and only one silylation is needed
38  canola oil was investigated and compared to unencapsulated extract and TBHQ.
39 concentrations up to 18-fold higher than the unencapsulated extract, enhancing microbial metabolism a
40 e compounds content in both encapsulated and unencapsulated extracts.
41 lication in bread and milk was compared with unencapsulated (fish oil) and microencapsulated omega3 P
42 act had lower oxidative alterations than the unencapsulated form.
43 l was inhibited by 2-3 fold, compared to its unencapsulated form.
44 th daily i.v. injections of 50 micrograms of unencapsulated (free) glucose oxidase (P = 0.002 by log-
45 sulated lanthanide complexes compared to the unencapsulated, free lanthanide complex.
46 er (P<0.05) concentration than corresponding unencapsulated fruit by-product.
47                                     However, unencapsulated GBS were also invasive but only when cult
48 response was overcome by coimmunization with unencapsulated GBS-III.
49 ls treated with equivalent concentrations of unencapsulated gelonin or gelonin encapsulated alone in
50 imited CP-mediated killing by anti-fHbp, the unencapsulated group A mutant paradoxically was more res
51 ned factor(s) in a cytoplasmic extract of an unencapsulated group A streptococcal strain was binding
52            C3a generated by encapsulated and unencapsulated group B and C strains was similar, but CP
53 m were previously healthy and presented with unencapsulated H. influenzae bacteremia.
54  influenzae and 2.90 (95% CI, 2.11-3.89) for unencapsulated H. influenzae compared with the backgroun
55               The incidence rate of invasive unencapsulated H. influenzae disease was 17.2 (95% CI, 1
56 have an increased susceptibility to invasive unencapsulated H. influenzae disease.
57                                              Unencapsulated H. influenzae infection during the first
58                                              Unencapsulated H. influenzae infection during the second
59 aturally occurring bactericidal activity for unencapsulated H. influenzae is largely due to IgM antib
60 mplement-dependent bactericidal activity for unencapsulated H. influenzae.
61 ts were separately expressed in nontypeable (unencapsulated) H. influenzae, which did not bind FH, an
62                                              Unencapsulated Haemophilus influenzae frequently causes
63                                              Unencapsulated Haemophilus influenzae is the second most
64                   Haemophilus influenzae was unencapsulated in all 10 episodes with known capsule typ
65    In contrast to R36A, neither inactivated, unencapsulated, intact Neisseria meningitidis nor Strept
66 poly-l-lysine-cross-linked microcapsules and unencapsulated islets were included as controls.
67  encapsulation and was comparable to that of unencapsulated islets.
68                 We engineered capsulated and unencapsulated isogenic mutant strains of groups A, B, C
69 ue sequence corresponds to a set of atypical unencapsulated isolates that may represent a distinct sp
70 spleen of mice infected with encapsulated or unencapsulated M. tuberculosis The combination of vaccin
71 e short physical half-life when delivered as unencapsulated material and in turn the short active hal
72         Similarly, primary immunization with unencapsulated MenC or GBS-III, to potentially prime CD4
73                       Purified CPSs bound to unencapsulated meningococci, simulated findings with nat
74 nsory difference/similarity between control, unencapsulated, microencapsulated, and nanoliposomal ome
75 s > 1,000-fold more effective by weight than unencapsulated monomeric cHyp.
76 lying on milder conditions, retains only the unencapsulated mRNA, which can be used to evaluate the e
77                           By differentiating unencapsulated mRNAs, empty LNPs and mRNA-loaded LNPs vi
78 wever, these mutants were as sensitive as an unencapsulated mutant to killing by normal human serum.
79 at poorly encapsulated wild-type strains and unencapsulated mutants of group A Streptococcus entered
80                                      Rather, unencapsulated mutants remain agglutinated within lumena
81     Using a mouse model, we demonstrate that unencapsulated mutants remain capable of nasal colonizat
82 is time point C3 was barely activated by the unencapsulated mutants.
83 , C, W-135, and Y strains and their isogenic unencapsulated mutants.
84 uraminidases) that are not shared with other unencapsulated nasopharyngeal S. pneumoniae.
85             HrpA mutants in encapsulated and unencapsulated NMB strains demonstrated biofilm growth e
86 he use of NO/Ar-ELIP was 7-fold greater than unencapsulated NO.
87  is not effective against non-b serotypes or unencapsulated non-typeable H. influenzae (NTHi).
88 n used in prior invasion studies, R6x, is an unencapsulated, nonpathogenic strain.
89                               The ability of unencapsulated (nontypeable) Haemophilus influenzae (NTH
90  oxidative stability during the storage than unencapsulated oil (p < 0.05) with better retention of E
91  oxidation stability of nanoencapsulated and unencapsulated oil were evaluated during 28days of stora
92 owed higher stability against oxidation than unencapsulated oil.
93 le of controlling peroxide value better than unencapsulated OLE.
94 an in control mice after injection of either unencapsulated or encapsulated S. aureus, suggesting tha
95 er administration of various doses of either unencapsulated or encapsulated S. aureus; furthermore, m
96 nriched samples while, samples enriched with unencapsulated or microencapsulated omega3 PUFAs showed
97 gainst acute otitis media caused by emerging unencapsulated otopathogens.
98 endritic cells in vitro, and was superior to unencapsulated peptide or peptide encapsulated in an ana
99 drug resistance, and ability to switch to an unencapsulated phenotype via insertion of virulence fact
100                     Inhibition occurred with unencapsulated Pn, encapsulated Pn expressing different
101                          A whole-cell killed unencapsulated pneumococcal vaccine given by the intrana
102 These studies suggest that killed whole-cell unencapsulated pneumococci given intranasally with an ad
103 were shown to contribute to the adherence of unencapsulated pneumococci, to human epithelial cells.
104  reduction in bacterial burden below that of unencapsulated polymyxin B.
105                       The instability of the unencapsulated prodrug in plasma allowed us to compare o
106 icrobiota, with empty microspheres ALINCH-E, unencapsulated quercetin UQ and media only Blank as para
107 h serotype 2 pneumococcal strain D39 and its unencapsulated R6 derivative.
108                                Additionally, unencapsulated RNA was observed with RNA staining after
109 erichia coli and Staphylococcus aureus; only unencapsulated ROSE showed bactericidal activity.
110                 The ultrafine fibers and the unencapsulated ROSE showed inhibitory action against Esc
111  whereas only 24% activity was preserved for unencapsulated rt-PA.
112 ated Streptococcus pneumoniae [including the unencapsulated S. pneumoniae, serotype 2 strain (R36A)]
113 of positive when incorporating new criteria (unencapsulated sheetlike enhancement) for DCE score of p
114 In mice with colitis, ultrasound delivery of unencapsulated siRNA against Tnf mRNA reduced protein le
115  signal resulting from both encapsulated and unencapsulated SRB molecules.
116 e relative humidity of 62.5 +/- 3.25%) in an unencapsulated state.
117 t challenge with lethal doses of toxinogenic unencapsulated Sterne 7702 spores and rabbits against ch
118                                          The unencapsulated strain CVD752 was quickly eliminated by t
119 s involved in the immune response, while the unencapsulated strain generally induced similar or great
120 cidal effect for Streptococcus mutans and an unencapsulated strain of Porphyromonas gingivalis follow
121  a college campus was caused by an atypical, unencapsulated strain of S. pneumoniae that was identica
122 ntact, inactivated Streptococcus pneumoniae (unencapsulated strain R36A) inhibits IgG responses to a
123  6B Streptococcus pneumoniae strain 603S and unencapsulated strain Rx1Delta lytA were modified to exp
124  In this study, transposon mutagenesis of an unencapsulated strain yielded an encapsulated mutant.
125  eliminated in developed countries; however, unencapsulated strains - nontypeable H. influenzae (NTHi
126                         DeltamltG mutants in unencapsulated strains accumulate inactivation mutations
127              These findings suggest that the unencapsulated strains capable of causing conjunctivitis
128 tative sensor gene, csrS, in three different unencapsulated strains yielded encapsulated mutant strai
129 ers of a distinct cluster of closely related unencapsulated strains.
130  complement-mediated opsonophagocytosis than unencapsulated strains.
131  strains compared to that in the presence of unencapsulated strains.
132 P. gingivalis strains are more virulent than unencapsulated strains; however, the contribution of cap
133 he assembly with the rate of the reaction of unencapsulated substrates reveals rate accelerations of
134                                Additionally, unencapsulated TFTs fabricated under ambient conditions
135 against P. aeruginosa PA01 was equivalent to unencapsulated tobramycin (minimum inhibitory concentrat
136 uorescence excitation spectra confirmed that unencapsulated TPT exhibits a red shift in its spectrum
137                             Encapsulated and unencapsulated type 18 streptococci were equally opsoniz
138                         USA300 isolates were unencapsulated, whereas 2 of 3 USA400 isolates produced
139                                          The unencapsulated white QD-LED has a long lifetime of 96 h

 
Page Top